Skip to main content
Top
Published in: Rheumatology International 7/2006

01-05-2006 | Original Article

The phenotype–genotype correlations of FMF patients: a single center study

Authors: Onur Sakallioglu, Faysal Gok, Suleyman Kalman, Davut Gul, Erdal Gokcay

Published in: Rheumatology International | Issue 7/2006

Login to get access

Excerpt

Familial Mediterranean fever (FMF) is an autosomal recessive disorder characterized by recurrent self-limited episodes of fever and serosal inflammation accompanied by acute-phase response. The cloned FMF gene (MEFV) with 30-point mutations maps to chromosome 16p and encodes a 781-amino acid protein called pyrin or marenostrin. The common mutations are M694V (Jews, Turks, and Armenians), M680I (Armenian), M694I (Arabs), E148Q (Europeans, Turks) and V726A located on exon 2 and mainly 10 [1]. Fever (96%), peritonitis (91%), pleurisy (57%), arthritis/arthralgia (45%), erisipelas-like erythema (13%), and amyloidosis (2%) are the cardinal signs of the disease [2]. With an insight to clarify the pathogenesis of FMF, we retrospectively studied the mutation–clinical correlations. …
Literature
1.
go back to reference Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R (2001) Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 9:634–637CrossRefPubMed Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R (2001) Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 9:634–637CrossRefPubMed
2.
go back to reference Ozen S (2003) Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr 162(7–8):449–54 (Epub) Ozen S (2003) Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr 162(7–8):449–54 (Epub)
3.
go back to reference Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R (1999) Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 103:e70CrossRefPubMed Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R (1999) Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 103:e70CrossRefPubMed
4.
go back to reference Yalcinkaya F, Topaloglu R, Yilmaz E, Emre S, Erken E, on behalf of the Turkish FMF Study Group (2002) Distribution of MEFV mutations and phenotype genotype analysis in Turkish patients with FMF: a nationwide study (abstract). Clin Exp Rheumatol 20(suppl 26):S90 Yalcinkaya F, Topaloglu R, Yilmaz E, Emre S, Erken E, on behalf of the Turkish FMF Study Group (2002) Distribution of MEFV mutations and phenotype genotype analysis in Turkish patients with FMF: a nationwide study (abstract). Clin Exp Rheumatol 20(suppl 26):S90
5.
go back to reference Yalcinkaya F, Akar N, Misiroglu M (1998) Familial Mediterranean fever amyloidosis and V726A mutation. N Engl J Med 338:933–934CrossRefPubMed Yalcinkaya F, Akar N, Misiroglu M (1998) Familial Mediterranean fever amyloidosis and V726A mutation. N Engl J Med 338:933–934CrossRefPubMed
6.
go back to reference Olgun A, Akman S, Kurt I, Tuzun A, Kutluay T (2004) MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis. Rheumatol Int Jan 15; [Epub ahead of print] Olgun A, Akman S, Kurt I, Tuzun A, Kutluay T (2004) MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis. Rheumatol Int Jan 15; [Epub ahead of print]
Metadata
Title
The phenotype–genotype correlations of FMF patients: a single center study
Authors
Onur Sakallioglu
Faysal Gok
Suleyman Kalman
Davut Gul
Erdal Gokcay
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-005-0045-8

Other articles of this Issue 7/2006

Rheumatology International 7/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.